DBV Technologies (DBVT) Total Liabilities (2015 - 2026)
DBV Technologies (DBVT) posted quarterly Total Liabilities of $62.8 million for Q2 2026, up 9.78% year-on-year from $57.2 million in Q2 2025, and up 7.53% on a QoQ basis from $58.4 million in Q1 2026.
DBV Technologies (DBVT) Total Liabilities (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Total Liabilities for 12 consecutive years, with $62.8 million the latest figure, recorded in Q2 2026.
- Quarterly Total Liabilities rose 9.78% year-over-year to $62.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $62.8 million (up 9.78% YoY) and the FY2025 annual result came in at $64.9 million, up 69.58% from the prior year.
- Total Liabilities grew to $62.8 million in Q2 2026 per DBVT's latest filing, from $58.4 million in the prior quarter.
- Over the last five years, Total Liabilities for DBVT reached as high as $64.9 million in Q4 2025 and fell as low as $34.2 million in Q1 2024.
- A 5-year average of $47.5 million and a median of $46.7 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities plunged 36.4% — and 2025, when it surged 69.58%.
- Year by year, Total Liabilities stood at $52.1 million in 2022, then retreated by 17.8% to $42.8 million in 2023, then declined by 10.58% to $38.3 million in 2024, then soared by 69.58% to $64.9 million in 2025, then fell by 3.24% to $62.8 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $62.8 million, $58.4 million, and $64.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 62.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.80 Mn |
| Mar 31, 2026 | 58.40 Mn |
| Dec 31, 2025 | 64.90 Mn |
| Sep 30, 2025 | 57.64 Mn |
| Jun 30, 2025 | 57.21 Mn |
| Mar 31, 2025 | 47.69 Mn |
| Dec 31, 2024 | 38.27 Mn |
| Sep 30, 2024 | 39.02 Mn |
| Jun 30, 2024 | 35.10 Mn |
| Mar 31, 2024 | 34.24 Mn |
| Dec 31, 2023 | 42.80 Mn |
| Sep 30, 2023 | 45.79 Mn |
| Jun 30, 2023 | 53.28 Mn |
| Mar 31, 2023 | 53.83 Mn |
| Dec 31, 2022 | 52.06 Mn |
| Sep 30, 2022 | 36.07 Mn |
| Jun 30, 2022 | 40.56 Mn |
| Mar 31, 2022 | 35.52 Mn |
| Dec 31, 2021 | 47.45 Mn |
| Sep 30, 2021 | 54.03 Mn |